Categories
Health

U.S. Covid pictures near turning pandemic tide

The pace of the spread of Covid-19 and the vaccination rate over the next few weeks are key factors in whether the US can avoid another surge in coronavirus infections, said Dr. Scott Gottlieb on Monday.

“If we could just buy a few more weeks and not really see an increase in infections somewhere in the country, we would have got to the point where we have enough vaccines in the population … it will.” was a pretty significant setback – combined with the warming weather – against really a fourth wave of infections, said Gottlieb, noting that states are significantly expanding immunization rights.

“I think we will achieve that,” added the former Commissioner of the Food and Drug Administration, who is now on Pfizer’s board of directors. “It’s a little touch and goes for the next two weeks because we’re seeing some increases in some parts of the country, but it will likely be regionalized. It will likely only be certain states where their cases are increasing.”

Approximately 28% of the US population have received at least one dose of Covid vaccine, and 15.5% were fully vaccinated on Sunday, according to the Centers for Disease Control and Prevention. Both the Pfizer and Moderna vaccines require two shots for full immunity protection, while Johnson & Johnson’s is a single dose. These are the only three emergency approved in the US

“When Israel hit about 25% of its vaccinated population, they started to see that [case] Declines attributed to vaccination. We are right at this tipping point, “Gottlieb said in an interview on CNBC’s” Squawk Box “.

The moving average of new infections is increasing in 30 states and Washington, DC in seven days, according to a CNBC analysis of Johns Hopkins University data. Gottlieb pointed to Michigan and the Tristate area of ​​New York, New Jersey, and Connecticut as “we see problems” regions.

Overall, the most recent weekly average of new Covid cases in the country is over 63,000, a 16% increase from the previous week. This is evident from the analysis by CNBC. That remains well below the nation’s high in early January of around 250,000.

In the seven-day period ending Friday, hospital admissions for Covid patients increased 4% from the previous week, but fell more than 71% from early January, according to the CDC.

The US recorded an average of 970 Covid deaths per day for the past week, a 3% decrease from the previous year, according to CNBC’s analysis.

Last week, White House chief medical officer Dr. Anthony Fauci, at a press conference that America was “on the corner” in the fight against Covid instead of going around the corner.

– CNBC’s Nate Rattner contributed to this report.

Dr. Scott Gottlieb is a CNBC employee and a member of the boards of directors of Pfizer, genetic testing startup Tempus, health technology company Aetion, and biotech company Illumina. He is also co-chair of Norwegian Cruise Line Holdings and Royal Caribbean’s Healthy Sail Panel.

Correction: The latest weekly average of new Covid cases in the country of the country is over 63,000, according to CNBC analysis, an increase of 16% from the previous week. An earlier version incorrectly characterized the characters.

Categories
Health

Easy methods to Vaccinate Homebound Seniors? Take the Photographs to Them.

A vial of vaccine. Five elderly homebound patients. Six hours to reach her before the vaccine goes bad.

Doctors at Northwell Health, the largest health care provider in New York State, set out last week to solve one of the toughest medical and logistical challenges facing the campaign to vaccinate Americans against the coronavirus: How to vaccinate the millions of seniors who live there live at home and are too frail or disabled to go to a clinic or line up at a vaccination site.

Members of the network’s home visit program had prepared for their first run. The delivery of Johnson & Johnson’s new coronavirus vaccine made the operation easier as a visit would do the trick.

A medical team designed a route that would include a cluster of homes not far from each other, starting with elderly patients in underserved communities badly affected by the virus. Doctors contacted patients well in advance of the visits, knowing that they would need enough time to consult with their families about the vaccination. Few refused; Most of them loved it.

Before the doctors took to the streets, they checked patients on the phone to make sure they were relatively healthy. Unexpected problems had to be avoided. Doctors ran against the clock: once they broke the vial seal and withdrew the first dose, they only had six hours to use the remaining vaccine or they had to throw it away.

“We’ll be sailing a tight ship, I think, but very compassionately,” said Dr. Karen Abrashkin, the program’s medical director, when a bulky high-tech cooler – actually a car refrigerator – was loaded in the back seat of her car last Wednesday and plugged into a cigarette lighter.

Inside was an ampoule the size of a thimble containing five doses of vaccine. “It’s a historic moment,” she said.

Her first stop was a Twofer, the home of a married couple in Hempstead, New York, Hector Hernandez, 81, a retired window cleaner who used to scrub high-rise buildings in Manhattan, and his wife Irma, 80, a retired seamstress, decided to get vaccinated after reviewing a potpourri of conflicting advice from friends and family.

“At first I was skeptical – is it safe?” Mr. Hernandez said. Two friends had warned him to be careful because the vaccine was new. But Ms. Hernandez’s cardiologist assured the couple it was safe, and another friend seemed confident that it was better to get the vaccine than not to get it.

The couple’s granddaughters, including one who was with Covid-19 for two weeks, advised to wait and see if the vaccine had any long-term side effects. In the end, said Mr Hernandez, her daughter persuaded her to get vaccinated.

“She called and said, ‘You have to make it because if you ever get Covid it can be really bad – you can’t breathe,” said Hernandez.

When Dr. Abrashkin pierced the vial’s seal with a syringe, Lorraine Richardson, a social worker who accompanied her, noted the time: 10:11. The two monitored the Hernandezes for side effects for 15 minutes and then set off. They had until 4:11 p.m. to reach three more patients.

At least two million Americans like the Hernandezes are tied to their homeland, a population that is virtually invisible. Most have multiple chronic conditions but cannot access basic home care. They often end up in hospitals and are prone to the coronavirus because of their ailments.

Updated

March 22, 2021, 8:27 p.m. ET

As public health officials drew up vaccine distribution plans, priority was given to the roughly five million residents and employees of communities such as nursing homes, where the coronavirus spread like wildfire in the early days of the pandemic. The virus killed at least 172,000 residents and employees, accounting for about a third of all deaths from Covid-19 in the United States.

However, the vast majority of Americans over 65 do not live in nursing homes or assisted living facilities, but rather in the community, where they are more difficult to reach. There is no central register for older people in their home country. Geographically dispersed and isolated, they are often difficult to find.

“This could be the next big hurdle for the elderly population,” said Tricia Neuman, senior vice president at the Kaiser Family Foundation. “So much of the vaccination has been a patchwork quilt at the state or local level, but this presents a whole different set of challenges.”

Vaccination rates among seniors have risen rapidly, with at least 60 percent vaccinated so far. Dr. However, Neuman noted that there is no system to get home: “Some people just can’t get to a vaccination site, so the challenge is getting the vaccine to where they live.”

In the absence of a centrally coordinated campaign aimed at home, local initiatives have sprung up across the country. Fire paramedics deliver vaccines to seniors in Miami Beach, Florida and Chicago. A visiting nurse service vaccinates older adults resident in East St. Louis, Illinois as part of the Meals on Wheels program.

Several health systems, like Geisinger Health in Pennsylvania and the Boston Medical Center, have identified hundreds of Americans and sent them vaccines. In Minnesota, nonprofits have set up pop-up vaccination clinics in senior housing and adult daycare.

On Monday, New York City announced that it would expand door-to-door vaccination efforts for seniors in the home, reaching at least 23,000 residents. According to Dr. Linda DeCherrie, the Mount’s clinical director, has the visiting physicians program at Mount Sinai, New York, which serves 1,200 residents, vaccinated 185 patients, and received the green light to vaccinate the senior caregivers of the Sinai at home program as well.

Northwell’s home visit program, which serves patients in Queens, Manhattan, and Long Island, calls for vaccinating 100 patients a week for the next 10 weeks. That schedule could be sped up if nurses were allowed to wear rescue medication in the event patients develop side effects such as anaphylactic shock.

While Dr. Abrashkin administered vaccines in Long Island last week, Dr. Konstantinos Deligiannidis, a colleague, found five elderly women in the Brentwood, NY area within four hours.

“You were so relieved,” he said. “They were all concerned – how could they get the vaccine since they couldn’t get out of the house?”

Dr. Abrashkin and Ms. Richardson visited and vaccinated two more elderly women on Wednesday before making their final stop in the sunny, plant-filled kitchen of Juanita Midgette, 73, a retired computer science and economics teacher with arthritis whom Eddie Murphy counts among her previous students. (Spoiler alert: he was a respectful student, she said, and she recommended his new movie, Coming 2 America.)

It was 12:31 when they knocked on the door. Ms. Midgette had heard mixed reviews of the coronavirus vaccine and had argued with her sister about it. But she hadn’t been able to travel to her North Carolina home and visit relatives since the pandemic, and she hoped the vaccine would give her the freedom to do so.

She believed in God and in science. Ms. Midgette said her research on the vaccine led her to conclude that “positivity far outweighs negativity”.

“My research shows me that with the data they have gathered so far, they are doing the best they can to save lives,” said Ms. Midgette.

“It reminds me of when we had the first computers and they were so big, but we started teaching with them,” she said. “Now they fit in the palm of your hand. If they had waited to get something smaller, the world would look different than it is today. “

After getting the shot, she asked Dr. Abrashkin: “Is it all over?”

“It’s hard to be isolated,” said Ms. Midgette. “I’m looking forward to somehow talking again.”

Categories
Health

Biden to hit purpose of 100 million pictures in first 100 days

President Joe Biden is poised to meet his goal of getting 100 million Covid-19 vaccination shots in his first 100 days as early as Thursday, a senior administrative official told NBC News.

The president had reached the goal ahead of schedule, said the official. Biden was sworn in as the 46th President of the United States on January 20, approximately 57 days ago. Biden said last week that he expected to hit the goal on day 60.

Biden is expected to make a “vaccination status” announcement later Thursday, where he can discuss the milestone.

Health experts say the president’s goal of 100 million shots in 100 days was an achievable benchmark. After a slower than expected rollout under former President Donald Trump, the rate of vaccination in the US has increased rapidly, firing an average of 2 to 3 million shots per day.

Since taking office, the Biden administration has worked to increase the supply of vaccine doses in the US after states complained that demand for the shots exceeded supply.

Last week the government announced it would buy 100 million additional doses of the Covid-19 vaccine from Johnson & Johnson. The deal would double the country’s supply of the J&J vaccine as the company has already signed a deal with the government to provide 100 million doses by the end of June. Merck Helps Manufacture J & J.’s Covid Vaccine

The government has also signed deals with drug makers Pfizer and Moderna for 600 million doses, which is enough to vaccinate 300 million Americans, as these two vaccines require two shots three to four weeks apart.

Biden is instructing states to qualify all adults ages 18 and older for the vaccines by May 1, he announced a week ago. The government will set up a website in May to help people find vaccination sites nearby, and the Centers for Disease Control and Prevention will be issuing new health and safety guidelines for those who have been vaccinated.

Although the pace of vaccination is increasing, there is still another problem with administering it: the hesitation of the vaccine.

Although clinical trial data shows the vaccines are safe and highly effective, just under half of US adults surveyed in December said they are very likely to be vaccinated, according to a study by the CDC.

Officials also encounter an unforeseen problem with the distribution of J & J’s recordings. Although J & J’s vaccine is a highly effective vaccine, particularly against serious illness and death, its rate of effectiveness is lower than that of Pfizer and Moderna, and therefore is perceived as inferior by some Americans.

The administration is also at risk of new, emerging variants. The CDC has announced that the B.1.1.7 variant, which was first identified in the UK, is expected to be the dominant strain in the US by the end of this month or early April. A study published in the British Medical Journal found the highly contagious strain was linked to a 64% higher risk of dying from Covid-19 than previous strains.

Senior health officials, including the White House Chief Medical Officer Dr. Anthony Fauci, urge Americans to get vaccinated as soon as possible. The virus cannot mutate if it cannot infect hosts and cannot multiply.

Correction: The heading of this story has been updated to reflect President Joe Biden’s goal of administering 100 million Covid vaccines during his first 100 days in office will be met as early as Thursday.

Categories
Health

Dentists, veterinarians and med college students licensed to manage pictures in U.S.

A U.S. Army soldier with the 2nd Armored Brigade Combat Team, 1st Infantry Division immunizes Jacklina Mendez with the COVID-19 vaccine on March 9, 2021 on the north campus of Miami Dade College in North Miami, Florida.

Joe Raedle | Getty Images

The Biden government will allow a wider range of medical professionals, including dentists, veterinarians, paramedics and medical students, to administer Covid-19 shots to bring the nation closer to normal by midsummer.

The U.S. Department of Health is using its powers under the Public Preparedness and Emergency Preparedness Act to empower more healthcare professionals and qualified students to manage the admissions, the agency said in a statement Friday.

That means dentists, paramedics, midwives, opticians, paramedics, medical assistants, podiatrists, respiratory therapists and veterinarians can start giving Covid-19 vaccines nationwide, according to HHS.

It also empowers “medical students, nursing students and other health care students in the professions listed in the PREP Act with appropriate training and professional supervision to act as vaccines,” the statement said.

The move comes after President Joe Biden announced Thursday night that he would instruct all U.S. states, tribes, and territories to qualify all adults ages 18 and older for the coronavirus vaccines by May 1.

The president, during his first prime-time address to the nation on the one-year anniversary of the pandemic, said the goal was for Americans to gather in small, face-to-face groups to celebrate July Fourth.

“That doesn’t mean everyone gets a shot right away, but May 1st is the date that any adult can sign up to get the shot,” Biden’s Covid Tsar Jeff Zients said at a press conference on Friday. “We expect an adequate vaccine supply for all adults in this country by the end of May.”

The US currently delivers an average of 2.2 million vaccines per day per week. About 65% of Americans age 65 and over are now vaccinated, Zients said. Only more than a quarter of adults 18 and older have received at least one vaccine, according to the latest data from the Centers for Disease Control and Prevention.

“We are making progress, but there is still a lot to be done,” he said.

On Monday, the CDC released its first guidelines for people who are fully vaccinated. These state that they can now converse with other vaccinated individuals inside without masks or social distancing.

Categories
Business

European Nations Droop Use of AstraZeneca Photographs Over Worries About Blood Clots

Italy’s suspension of another batch was tied to a man in Sicily who died after receiving his shot. It is unclear whether a blood clot was involved.

The vaccine manufactured by AstraZeneca has been injected into more than 142,000 people in Denmark, which has a population of around six million.

The Danish Health Minister Magnus Heunicke said on Twitter that it was “currently not possible to determine whether there is a connection”. He added: “We acted early, it needs a thorough investigation.”

Denmark had already cut the target for the completion of its vaccination campaign, partly due to delivery delays. The safety break will delay it further.

AstraZeneca’s vaccine was screened for potential safety issues over the past year while being tested in clinical trials. Two vaccinated volunteers in the UK developed neurological symptoms related to transverse myelitis, an inflammatory syndrome that affects the spinal cord and is often caused by viral infections.

These concerns temporarily put the vaccine to a halt around the world, but the investigation ultimately found no evidence to link the symptoms to the vaccine. One of the sick participants was later found to have an undiagnosed case of multiple sclerosis.

Since then, more than 70 countries have approved the vaccine, with the exception of the United States, where regulators are waiting for data from a large clinical trial expected in the next few weeks. A Food and Drug Administration decision to approve AstraZeneca’s vaccine is likely more than a month away.

The largest real world data on the safety of the vaccine comes from the UK, which had given 9.7 million doses in the last month. The UK Medicines Agency, the regulator of medicines and health products, said: “The number and types of suspected adverse reactions reported to date are not uncommon when compared to other types of vaccines routinely used.”

Rebecca Robbins reported from Bellingham, Washington, and Thomas Erdbrink from Amsterdam. Jason Horowitz and Emma Bubola reported from Italy, Benjamin Mueller from London and Denise Grady from New York.

Categories
Business

Coronavirus Vaccine Finder Goals to Assist Individuals Get Photographs

Despite the progress, getting appointments for vaccinations has been a huge disappointment for many people. Appointments will be filled within minutes depending on availability. States, local health departments, and pharmacy chains have their own registration websites, which in many cases do not share data with one another. The CDC has its own Vaccine Administration System (VAMS) which some states use to register people for vaccinations and collect important data. However, state officials have complained that this is clunky.

Disgruntled people have taken matters into their own hands, setting up online navigator tools and Facebook groups for “vaccine hunters” in cities like Los Angeles and New Orleans to connect people with available doses.

Updated

Apr. 24, 2021, 8:33 p.m. ET

When the VaccineFinder portal goes live this week, it will include a few drug and grocery stores nationwide, as well as many other locations such as mass vaccination sites in Alaska, Indiana, Iowa, and Tennessee.

Kristen Nordlund, a CDC spokeswoman, said the agency is encouraging vaccination centers to “provide accurate and up-to-date information on the location, hours and availability of vaccines so that Americans can more easily find vaccination sites.”

Dr. Marcus Plescia, Chief Medical Officer of the Association of State and Territorial Health Officials, said, “I think people are optimistic and are eagerly awaiting it.” big confusion to come, but I think we just have to work it through. “

In the first few weeks of the vaccine’s launch, it was relatively easy to find doses when eligible individuals – healthcare workers, residents and long-term care workers – were mainly vaccinated where they lived or worked.

However, since then states have expanded their eligibility criteria to include the elderly, people with certain medical conditions, and certain frontline workers. Additional locations for vaccine dispensing have been added, including stadiums and local pharmacies.

Categories
Health

Moderna to start trials of Covid vaccine booster photographs for variant from South Africa

A health care worker gives a picture of Moderna COVID-19 to a woman at a pop-up vaccination site operated by SOMOS Community Care during the coronavirus disease (COVID-19) pandemic in New York on January 29, 2021 Vaccine.

Facebook Facebook Logo Log in to Facebook to connect with Mike Segar Reuters

Moderna announced on Wednesday that a new Covid-19 vaccine, which is said to offer better protection against the highly contagious variant of coronavirus that is widespread in South Africa, has been delivered to the National Institutes of Health.

The vaccine – which Moderna names mRNA-1273.351 – can be tested in an early clinical trial to see if it can be used as a booster against the South African strain, also known as B.1.351. Moderna has found that its current two-dose regimen produces a weaker immune response against the South African strain, although the company said the antibodies in patients remain above levels expected to protect against the virus.

“Moderna is committed to making as many updates as necessary to our vaccine until the pandemic is under control,” said the company’s CEO, Stephane Bancel, in a press release. “We hope to show that booster doses can be given at lower doses when needed, which will allow us to make many more doses available to the global community when needed in late 2021 and 2022.”

US health officials are increasingly concerned about new, emerging variants of the virus, particularly strain B.1.351, which has been shown to reduce the effectiveness of vaccines both in market and in development. Over the past few weeks, the White House Chief Medical Officer, Dr. Anthony Fauci, urged Americans to get vaccinated as soon as possible before potentially new and even more dangerous variants of the virus emerge.

As of Tuesday, the Centers for Disease Control and Prevention had identified 1,881 cases of variant B.1.1.7, which were first found in the UK. The US authorities said they had identified 46 cases of the strain B.1.351 from South Africa and five cases of P.1, a variant first discovered in Brazil. The more people become infected, the more likely it is that even more problematic mutations will occur, say medical experts.

On Monday, the Food and Drug Administration released updated guidelines that modified Covid-19 vaccines that work to protect against new, emerging variants may be approved without the need for lengthy clinical trials. The FDA would approve the new vaccine as an amendment to a company’s originally approved emergency filing, thereby expediting the regulatory review process.

Moderna first announced on January 25 that it was working on a booster shot to protect itself against the variant in South Africa.

The company announced on Wednesday that it is evaluating three approaches to increasing immunity. The first approach would use variant-specific booster vaccinations such as mRNA-1273.351, but at a lower dose than the original vaccine. The second would combine the original vaccine with a variant-specific vaccine into a single shot at 50 micrograms or less, Moderna said. The third would test a third shot of the original vaccine at a lower dose.

Moderna said it also plans to test the original vaccine and new booster shot as a two-dose regimen in people without coronavirus antibodies.

Separately, the company also announced that it is expected to produce up to 1.4 billion doses of Covid-19 vaccine by 2022. It has also raised its global base production estimate from 600 million cans to 700 million cans this year.

According to Moderna, the 1.4 billion doses in 2022 assume the vaccine will be given at its current level of 100 micrograms. If the vaccine turns out to be effective at a lower dose, the company could deliver up to 2.8 billion doses by 2022, the company said.

Moderna has signed a contract with the US government for 300 million cans. The company has shipped around 55 million cans to the US to date. The first 100 million cans are expected to be shipped to the US by the end of the first quarter of 2021, the second 100 million cans by the end of May 2021, and the third 100 million cans by the end of July 2021.

Categories
Business

FDA says photographs for brand spanking new variants will not want giant medical trials

Erick Vazquez receives the Pfizer vaccine during an event to vaccinate approximately 500 healthcare workers and adults over 65 years of age against COVID-19 organized by Labor Community Services, the Los Angeles Federation of Labor, and the St. Johns Well Child and Family Center shaped work of love, in Pico Union, February 13, 2021 in Los Angeles, CA.

Dania Maxwell | Los Angeles Times | Getty Images

The Food and Drug Administration announced Monday that modified Covid-19 vaccines against new, emerging variants can be approved without the need for lengthy clinical trials.

The new guidelines, published in a 24-page document on the FDA’s website, would release the new vaccines as an amendment to a company’s originally approved emergency application, according to the FDA. The company would have to submit new data showing the modified vaccine produces a similar immune response and is safe, similar to annual flu vaccines.

“Preliminary reports from clinical trials evaluating COVID-19 vaccine candidates in several countries, including South Africa, have contributed to concerns that the vaccine may be less effective against variant B.1.351 than against the original virus,” the wrote Agency found in the document with reference to the strain in South Africa. “Therefore, there is an urgent need to initiate the development and evaluation of vaccines against these SARSCoV-2 variants.”

The updated guidelines come because U.S. health officials, including White House Chief Medical Officer Dr. Anthony Fauci, fear the virus could potentially mutate enough to evade the protection of current vaccines and reverse advances in the pandemic.

For the past few weeks, officials have urged Americans to get vaccinated as soon as possible before potentially new and even more dangerous variants of the virus emerge.

As of Sunday, the Centers for Disease Control and Prevention had identified 1,661 cases of variant B.1.1.7, which were first identified in the UK. The agency has identified 22 cases of the B.1.351 strain from South Africa and five cases of P.1, a variant first identified in Brazil.

The FDA approved Pfizer and Moderna’s emergency vaccines in December, and the two drug makers have since announced plans to change their vaccines to target new variants. The guidelines could speed up the regulatory review process for the vaccines.

Public health officials and infectious disease experts said there was a high chance that Covid-19 would become an endemic disease, meaning it will never go away completely, although it will likely spread at lower levels than it is now. Health officials must constantly look for new variants of the virus so scientists can make vaccines against them, medical experts say.

Richard Webby, director of a World Health Organization flu center at St. Jude Children’s Research Hospital, said the clearance process for modified Covid-19 vaccines may be very similar to the procedure for annual flu shots.

The U.S. and other nations need to step up their surveillance of new tribes and then make regular recommendations as to which variants to target, he said in a recent interview. “It’s not there for Covid at the moment.”

Categories
Business

Belief in pictures must be earned after mistreatment of Blacks and Latinos

Dr. Torian Easterling is the First Assistant Commissioner and Chief Equity Officer for the New York Department of Health

There is one essential element to the success of a vaccination program: people’s trust in the vaccine and the institutions that give it. Trust in the Covid-19 vaccine is just as valuable as our vaccine supply. But after decades of racist divestment and medical abuse, the black and Latin American communities have every reason to be skeptical.

A recent CDC vaccine reluctance survey yielded disappointing – if not surprising – results. In September, 56% of black Americans said they would get vaccinated, and by December – after the FDA approved Pfizer and Moderna vaccines for emergency use – that percentage had dropped to 46%. By comparison, 70% of white Americans responded that they intend to receive the vaccine in December. Another Kaiser Foundation survey found a similar trend among Hispanic Americans that only 42% would like to receive the vaccine.

But more revealing in these polls is exactly why blacks and Latinos aren’t ready to get the shot. The main reasons were side effects concerns, the vaccine being developed too quickly, and many said they don’t trust the government.

It is clear that much remains to be done. To win the trust of New York Black and Latino people we need to be inclusive, reach communities, hear voices, values ​​and opinions. The responsibility cannot lie with the individual. It must be up to institutions and public health officials to treat people with respect so that they have a reason to trust and make informed decisions. Imagine we put our arms around communities and let them know we have them.

In the past few months, I have participated in dozens of listening sessions with ward groups, faith leaders, and local health care providers in black and Latin American churches. We talked about misconceptions and fears about the Covid-19 vaccine and how decades of racism and poor treatment by the medical community have created suspicion.

When comparing the medical experiences of Black, Latino, and White, the contrast is unsettling and begins literally from the moment we are born. As we know, there are persistent and intolerable differences in maternal health outcomes.

Unfortunately, the unequal treatment continues into adulthood. People of color are less likely to receive the same treatment for everything from palliative care to treating chronic diseases. In many large cities, there is also unequal access to quality healthcare and, often, hospital segregation.

In my own conversations with New Yorkers, trust in government and medicine has been an ongoing issue. And while they are painful, they give us the opportunity to move into a place of healing.

Last summer we heard the call for change when hospital stays and deaths in Covid-19 exposed the health impact of racism and the murder of George Floyd exposed structural racism in our country. The movement prompted the health department to declare racism a public health problem and the city to set up the task force on racial inclusion.

Now we are maintaining that commitment as we introduce vaccines to the city. To build confidence in the vaccine, New York City unveiled a share plan rooted in 33 neighborhoods with high Covid-19 case and death rates, and historical inequalities such as disease burden and crowded living conditions.

Our central topic is community-oriented public relations work at the neighborhood level. Townhalls and webinars provide information about the safety and effectiveness of the vaccine. However, empowering people to make their own decisions needs to be done in small groups with trustworthy voices. That’s why we partner with hundreds of community-based organizations to be trusted ambassadors. We need to meet people where they are – on the phone, at home, online, or door to door – in the languages ​​New Yorkers speak. Communication must – and was – be open, honest and clear.

We also use data to inform our work. We sent a letter to health care providers across the city asking them to collect the race and ethnicity of the Covid-19 vaccine recipient and report it to the citywide vaccination registry. We’re releasing race and ethnicity data on Covid-19 tests and positivity, and we’ve just added postcode-level data.

We want to know who is receiving the vaccine and where there are gaps so we can get the vaccine to the right places. As the vaccine supply grows, we are working with community partners to identify the best locations for people to be vaccinated and to ensure connection with resources and services. The majority of our city vaccination sites are already in the 33 priority neighborhoods, but we are growing and prioritizing communities with longstanding inequalities that need the vaccine the most.

As we move forward with our vaccine rollout, racial justice will remain our most enduring core value. We know that we have to identify racism, take responsibility and do the necessary work to instill trust in everyday people for our vaccination strategy to be successful.

Categories
Health

As Hundreds of thousands Get Covid Vaccine Pictures, F.D.A. Struggles With Security Monitoring

“It’s great for routine activities, but when it comes to security surveillance, size is all,” said Dr. Daniel Salmon, director of the Institute for Vaccine Safety at Johns Hopkins University and former federal vaccine officer. “The bigger it is, the faster you get an answer. At some point the VSD is going to get a really good answer – probably one of the best answers out there because they are so good at it. But in a pandemic, time is not on our side. “

Few serious problems have been reported through these channels to date and no deaths have been clearly linked to the vaccines. The 30-year initiative, known as the Vaccine Adverse Event Reporting System (VAERS), relies on self-reported cases from patients and health care providers.

Health officials say the two vaccines already approved for use appear to be reasonably safe so far. There have been some serious allergic reactions, including anaphylaxis, but they are treatable and are considered rare. The rate at which anaphylaxis has occurred to date – 4.7 cases per million doses for the vaccine from Pfizer and BioNTech and 2.5 cases per million for the vaccine from Moderna – is in line with other widely used vaccines.

Bruising and bleeding caused by decreased platelet counts have also been reported, although it is not known whether they are vaccine-related or accidental. A total of 9,000 adverse events were reported, of which 979 were classified as serious and the remainder classified as non-serious according to the latest available CDC report.

In interviews, public health experts, including current and former FDA and CDC officials, expressed the need to improve on the old “passive” surveillance that relies on self-reporting. They said funding shortages, turf wars and bureaucratic hurdles had slowed BEST, officially known as the Biologics Evaluation Safety Initiative, in preparation for monitoring Covid vaccines.